News
Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables & Leachables testing services at its US Technology Excellence Center
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global...
Press Releases
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma,...
News
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in...
Press Releases
Biocon Biologics and Mylan Announce Launch of Semglee in the U.S. to Expand Access for Patients Living with Diabetes
Biocon Biologics India Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., and Mylan N.V. announced the U.S. launch...
News
AstraZeneca begins Phase III trial of Covid-19 vaccine in US
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed...
Press Releases
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
Gilead Sciences, Inc. announced an agreement with Jounce Therapeutics, Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
News
Sanofi provides update on Kevzara Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read